Impact of apolipoprotein A5 (APOA5) polymorphisms on serum triglyceride levels in schizophrenic patients under long-term atypical antipsychotic treatment. [electronic resource]
Producer: 20120425Description: 22-9 p. digitalISSN:- 1814-1412
- Adult
- Antipsychotic Agents -- pharmacology
- Apolipoprotein A-V
- Apolipoproteins A -- genetics
- Benzodiazepines -- pharmacology
- Clozapine -- pharmacology
- Female
- Haplotypes
- Humans
- Hypertriglyceridemia -- blood
- Male
- Middle Aged
- Olanzapine
- Polymorphism, Genetic
- Polymorphism, Single Nucleotide
- Risperidone -- pharmacology
- Schizophrenia -- blood
- Taiwan
- Triglycerides -- blood
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.